Literature DB >> 7258098

Electrophysiologic studies of supraventricular tachycardia in children. I. Clinical-electrophysiologic correlations.

A Garson, P C Gillette.   

Abstract

We investigated the clinical features, surface ECG findings, associated with congenital heart disease (CHD), and status at follow-up in 103 children who underwent intracardiac electrophysiologic evaluation of supraventricular tachycardia (SVT). Age at catheterization ranged from 2 days to 17 years (mean 4.2 years). Diagnosis of the mechanism was based upon standard electrophysiologic techniques. Of the 103 patients, 37 had reentry without a bypass tract (10 sinoatrial node, two atrial muscle, and 25 atrioventricular node); 51 had reentry with a bypass tract (28 manifest Wolff-Parkinson-White [WPW], 18 unidirectional retrograde accessory pathway [URAP], an five Lown-Ganong-Levine); and 15 had an ectopic focus (11 atrial, four junctional). Distinguishing features among the common types are depicted in Table III. We conclude that in children the various mechanisms of SVT (1) are likely to be found in different clinical situations, (2) have a different potential for surgical cure, and (3) have a different prognosis for long-term treatment. Since curative surgery was theoretically possible in 57% of our patients (WPW, concealed WPW, atrial, and junctional ectopic), we recommend electrophysiologic study in any patient who has had frequent recurrences of SVT for longer than 1 year and who requires drugs in addition to digoxin for treatment.

Entities:  

Mesh:

Year:  1981        PMID: 7258098     DOI: 10.1016/s0002-8703(81)80015-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Surgery for ventricular and atrial tachyarrhythmias in children: state of the art, 1992.

Authors:  D A Ott; A Garson
Journal:  Tex Heart Inst J       Date:  1992

Review 2.  Supraventricular tachycardia in children: diagnosis and management.

Authors:  A V Mehta
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

Review 3.  Contributions of the Texas Children's Hospital Pediatric Cardiology Program to the field of pediatric cardiology.

Authors:  J T Bricker
Journal:  Tex Heart Inst J       Date:  1997

Review 4.  The role of electrophysiologic studies in pediatric cardiology: an overview.

Authors:  A V Mehta
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

5.  Management of paroxysmal tachycardia.

Authors:  J L Wilkinson
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

Review 6.  Surgery without thoracotomy: transcatheter management of pediatric heart disease.

Authors:  P S Rao
Journal:  Indian J Pediatr       Date:  1984 Nov-Dec       Impact factor: 1.967

Review 7.  Management of Supraventricular Tachycardia in Infants.

Authors:  Chalese Richardson; Eric S Silver
Journal:  Paediatr Drugs       Date:  2017-12       Impact factor: 3.022

8.  Impact of transesophageal electrophysiologic study to elucidate the mechanism of arrhythmia on children with supraventricular tachycardia and no preexcitation.

Authors:  Béatrice Brembilla-Perrot; A Moulin-Zinsch; J M Sellal; J Schwartz; A Olivier; P Y Zinzius; C De Chillou; D Beurrier; M Rodermann; G Goudote; H Al Amoura; A Terrier de la Chaise; J Lemoine; J Rizk; J P Lethor; J L Anne Tisserand; S Taïhi; F Marçon
Journal:  Pediatr Cardiol       Date:  2013-04-23       Impact factor: 1.655

9.  Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone.

Authors:  E Shahar; Z Barzilay; A A Shem-Tov; I Shohet; M Frand
Journal:  Arch Dis Child       Date:  1983-03       Impact factor: 3.791

10.  Factors of negativity of electrophysiological study in children and teenagers complaining of tachycardia and prognostic significance.

Authors:  Béatrice Brembilla-Perrot; Alice Brembilla; Anne Moulin-Zinsch; Jean Marc Sellal; Arnaud Olivier; Vladimir Manenti; Thibaut Villemin; Jean Paul Lethor; Samira Taihï; Joseph Rizk; Marc Rodermann; François Marçon; Nicolas Girerd
Journal:  Pediatr Cardiol       Date:  2014-07-29       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.